• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy.

作者信息

Glicksman Rachel M, Loblaw Andrew, Cheung Patrick

机构信息

Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.

出版信息

Clin Transl Radiat Oncol. 2024 Nov 14;50:100888. doi: 10.1016/j.ctro.2024.100888. eCollection 2025 Jan.

DOI:10.1016/j.ctro.2024.100888
PMID:39634197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11615872/
Abstract
摘要

相似文献

1
Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy.老年男性接受大分割放疗时的选择性盆腔淋巴结照射
Clin Transl Radiat Oncol. 2024 Nov 14;50:100888. doi: 10.1016/j.ctro.2024.100888. eCollection 2025 Jan.
2
Elective Pelvic Nodal Irradiation With a Simultaneous Hypofractionated Integrated Prostate Boost for Localised Prostate Cancer: Ready for Prime Time?局部前列腺癌的选择性盆腔淋巴结放疗联合同期缩野前列腺加量放疗：是否已准备好应用于临床？
Clin Oncol (R Coll Radiol). 2020 Mar;32(3):181-188. doi: 10.1016/j.clon.2019.12.002. Epub 2020 Jan 8.
3
Target volume delineation for radical radiotherapy of early oesophageal carcinoma in elderly patients.老年早期食管癌根治性放疗的靶区勾画
Cancer Radiother. 2017 Feb;21(1):34-39. doi: 10.1016/j.canrad.2016.08.129. Epub 2016 Dec 29.
4
Moderately Hypofractionated Radiotherapy and Androgen Deprivation Therapy for High-risk Localised Prostate Cancer: Predictors of Long-term Biochemical Control and Toxicity.中危局限性前列腺癌的适度分割放疗联合雄激素剥夺治疗：长期生化控制和毒性的预测因素。
Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e52-e60. doi: 10.1016/j.clon.2021.08.010. Epub 2021 Aug 26.
5
Ultra hypofractionated extended nodal irradiation using volumetric modulated arc therapy for oligorecurrent pelvic nodal prostate cancer.采用容积旋转调强弧形治疗技术进行超分割扩展淋巴结照射治疗寡复发盆腔淋巴结前列腺癌。
Med Dosim. 2021;46(4):411-418. doi: 10.1016/j.meddos.2021.05.002. Epub 2021 Jun 18.
6
Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial.挽救性低分割加速放疗与标准放疗治疗根治性前列腺切除术后生化复发的比较（SHARE）：一项前瞻性、随机、开放标签、优效性、多中心试验方案。
Trials. 2021 Oct 21;22(1):728. doi: 10.1186/s13063-021-05708-5.
7
[Lung cancer: is there a place for elective nodal irradiation?].[肺癌：选择性淋巴结照射是否有意义？]
Cancer Radiother. 2006 Nov;10(6-7):354-60. doi: 10.1016/j.canrad.2006.09.004. Epub 2006 Oct 10.
8
Elective pelvic nodal irradiation for elderly patients with high-risk prostate cancer: A more patient-oriented approach.老年高危前列腺癌患者的选择性盆腔淋巴结照射：一种更以患者为导向的方法。
Clin Transl Radiat Oncol. 2024 Dec 31;51:100909. doi: 10.1016/j.ctro.2024.100909. eCollection 2025 Mar.
9
Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer.高危前列腺癌的调强适形放射治疗盆腔淋巴结剂量递增的 I 期临床试验。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):184-90. doi: 10.1016/j.ijrobp.2010.09.018. Epub 2010 Dec 14.
10
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.局部高危前列腺癌选择性盆腔淋巴结照射与同期低分割整合前列腺增敏放疗：前瞻性临床试验的长期结果。
Radiother Oncol. 2021 Oct;163:21-31. doi: 10.1016/j.radonc.2021.07.018. Epub 2021 Jul 26.

本文引用的文献

1
Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials.前列腺癌超分割与适度分割及常规分割放疗中选择性盆腔淋巴结照射：3项前瞻性临床试验的结果
Clin Transl Radiat Oncol. 2024 Aug 16;49:100843. doi: 10.1016/j.ctro.2024.100843. eCollection 2024 Nov.
2
Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial.低分割、剂量递增放疗治疗高危前列腺癌：前列腺癌研究-5 的安全性分析，这是一项由魁北克生殖泌尿科肿瘤放疗组领导的 3 期临床试验。
Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):52-62. doi: 10.1016/j.ijrobp.2023.05.014. Epub 2023 May 22.
3
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial.高危和极高危前列腺癌的前列腺放疗与全盆腔放疗比较（POP-RT）：来自 III 期随机对照试验的结果。
J Clin Oncol. 2021 Apr 10;39(11):1234-1242. doi: 10.1200/JCO.20.03282. Epub 2021 Jan 26.
4
Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial.高危前列腺癌患者行前列腺区或全盆腔放疗的晚期毒性和生活质量（POP-RT）：一项随机试验。
Radiother Oncol. 2020 Apr;145:71-80. doi: 10.1016/j.radonc.2019.12.006. Epub 2020 Jan 7.
5
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.激素治疗与放疗靶区大小在局部进展性前列腺癌中的研究（NRG/RTOG9413）：一项随机、3 期临床试验的长期结果。
Lancet Oncol. 2018 Nov;19(11):1504-1515. doi: 10.1016/S1470-2045(18)30528-X. Epub 2018 Oct 10.
6
Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study.盆腔放疗在局限性前列腺腺癌中是否有作用？GETUG-01随机研究长期生存结果的更新
Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):759-769. doi: 10.1016/j.ijrobp.2016.06.2455.
7
Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.盆腔放疗在局限性前列腺腺癌中是否有作用？GETUG-01的初步结果。
J Clin Oncol. 2007 Dec 1;25(34):5366-73. doi: 10.1200/JCO.2006.10.5171.
8
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.比较全盆腔放疗与仅前列腺放疗以及新辅助与辅助联合雄激素抑制的III期试验：放射肿瘤学组9413
J Clin Oncol. 2003 May 15;21(10):1904-11. doi: 10.1200/JCO.2003.05.004.